Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LF0B
|
|||
| Drug Name |
Tricyclic compound 8
|
|||
| Synonyms |
PMID27568917-Compound-Figure1(a)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H13N3O2
|
|||
| Canonical SMILES |
CN1C(=O)C(NC1=O)CC2=CNC3=CC=CC=C32
|
|||
| InChI |
1S/C13H13N3O2/c1-16-12(17)11(15-13(16)18)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,14H,6H2,1H3,(H,15,18)
|
|||
| InChIKey |
PANAMPMZPUJRLL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 74311-00-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Receptor-interacting protein 1 (RIPK1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Receptor-interacting protein 1 (RIPK1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents.Expert Opin Ther Pat. 2016 Nov;26(11):1239-1256. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.